Khubchandani Hospitals was deemed substantively liquidated in 1QFY2020.
IHH Healthcare has reported a 217% y-o-y surge in earnings of RM375.6 million ($120.1 million) for the 1QFY2021 ended March, due to strong EBITDA growth.
This comes without the impairment for Global Hospitals in India and foreign currency translation losses for its joint venture project, Khubchandani Hospitals in India that was factored in during the corresponding period the year before.
